Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation

Status Terminated

Clinical Trial Summary

The overall aim of this study is to explore the effects of flaxseed supplementation and determine whether it is a feasible and potentially effective dietary intervention among women with polycystic ovarian syndrome (PCOS). Women, ages 18-45, with clinically confirmed PCOS (N=20) will be scheduled for baseline measures and then instructed and given supplies necessary to follow a flaxseed supplemented (30 g/day) diet for a period of three months, whereupon follow-up measures will be taken. Subjects will be asked to resume their typical (unsupplemented) diet for another three months and a second set of follow-up measures will be taken. Baseline levels of bioavailable and total testosterone, fasting insulin, glucose, and triglycerides (TG), total/LDL/HDL cholesterol, body weight, degree of hirsutism and acne, and menstrual cyclicity will be compared to levels at 3 and 6 month follow-up. The overall hypothesis (based upon our work in men at risk for prostate cancer and data from one case-study conducted in a woman with confirmed PCOS) is that during the time women receive flaxseed supplementation they will experience reduced serum levels of testosterone, and total and LDL cholesterol, as well as clinical evidence of hirsutism. Given the pilot nature of this study, statistical analyses will be limited to simple descriptive statistics. We have observed no negative side effects, other than minor gastro-intestinal occurrences (i.e., temporary increased flatulence, borborygmi, increased number of stools, etc.) associated with flaxseed supplementation in our previous studies either with short or long-term use. Flaxseed supplementation will be discontinued if indicated and the events reported to the institutional review board.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00693082
Study type	Interventional
Source	Duke University
Contact
Status	Terminated
Phase	Phase 2
Start date	August 2007
Completion date	June 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02244567` - Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women	Phase 1
Completed	`NCT01653743` - Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women	Phase 3
Completed	`NCT01672801` - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT	N/A
Completed	`NCT00579540` - Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels	N/A
Terminated	`NCT05084274` - Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program	N/A
Completed	`NCT03717935` - Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS	N/A
Withdrawn	`NCT01716429` - Healthy Eating for Reproductive Health: Greenville	N/A
Active, not recruiting	`NCT02896452` - Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
Recruiting	`NCT05146063` - LNK in Polycystic Ovary Syndrome With Insulin Resistance
Recruiting	`NCT06303219` - Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome	N/A
Completed	`NCT02869750` - The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome
Completed	`NCT01237106` - In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)	N/A
Completed	`NCT01185704` - Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)	Phase 3
Recruiting	`NCT04029805` - Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels	Phase 1/Phase 2
Completed	`NCT01675843` - Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome	Phase 4
Completed	`NCT01577017` - The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)	Phase 3
Completed	`NCT00478504` - Letrozole Versus Clomifene Citrate for Ovulation Induction	Phase 4
Completed	`NCT05215223` - Effect of Whole Body Vibration on Insulin Resistance in Females With Polycystic Ovarian Syndrome	N/A
Completed	`NCT03358199` - LOD Before IVF/ICSI in PCOS Patients With High AMH	N/A
Completed	`NCT02436226` - Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS	Phase 4